Show simple item record

dc.contributor.authorKim, W
dc.contributor.authorLe, TM
dc.contributor.authorWei, L
dc.contributor.authorPoddar, S
dc.contributor.authorBazzy, J
dc.contributor.authorWang, X
dc.contributor.authorUong, NT
dc.contributor.authorAbt, ER
dc.contributor.authorCapri, JR
dc.contributor.authorAustin, WR
dc.contributor.authorVan Valkenburgh, JS
dc.contributor.authorSteele, D
dc.contributor.authorGipson, RM
dc.contributor.authorSlavik, R
dc.contributor.authorCabebe, AE
dc.contributor.authorTaechariyakul, T
dc.contributor.authorYaghoubi, SS
dc.contributor.authorLee, JT
dc.contributor.authorSadeghi, S
dc.contributor.authorLavie, A
dc.contributor.authorFaull, KF
dc.contributor.authorWitte, ON
dc.contributor.authorDonahue, TR
dc.contributor.authorPhelps, ME
dc.contributor.authorHerschman, HR
dc.contributor.authorHerrmann, K
dc.contributor.authorCzernin, J
dc.contributor.authorRadu, CG
dc.date.accessioned2016-06-20T16:35:19Z
dc.date.available2016-06-20T16:35:19Z
dc.date.issued2016-04-12
dc.identifier.bibliographicCitationKim, W., Le, T. M., Wei, L., Poddar, S., Bazzy, J., Wang, X., Uong, N. T., Abt, E. R., Capri, J. R., Austin, W. R., Van Valkenburgh, J. S., Steele, D., Gipson, R. M., Slavik, R., Cabebe, A. E., Taechariyakul, T., Yaghoubi, S. S., Lee, J. T., Sadeghi, S., Lavie, A., Faull, K. F., Witte, O. N., Donahue, T. R., Phelps, M. E., Herschman, H. R., Herrmann, K., Czernin, J. and Radu, C. G. [18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity. Proceedings of the National Academy of Sciences of the United States of America. 2016. 113(15): 4027-4032. DOI: 10.1073/pnas.1524212113.en_US
dc.identifier.otherESSN: 1091-6490
dc.identifier.urihttp://hdl.handle.net/10027/20782
dc.descriptionThis is a copy of an article published in the Proceedings of the National Academy of Sciences © 2016 National Academy of Sciences Publications.en_US
dc.description.abstractDeoxycytidine kinase (dCK), a rate-limiting enzyme in the cytosolic deoxyribonucleoside (dN) salvage pathway, is an important therapeutic and positron emission tomography (PET) imaging target in cancer. PET probes for dCK have been developed and are effective in mice but have suboptimal specificity and sensitivity in humans. To identify a more suitable probe for clinical dCK PET imaging, we compared the selectivity of two candidate compounds-[(18)F]Clofarabine; 2-chloro-2'-deoxy-2'-[(18)F]fluoro-9-β-d-arabinofuranosyl-adenine ([(18)F]CFA) and 2'-deoxy-2'-[(18)F]fluoro-9-β-d-arabinofuranosyl-guanine ([(18)F]F-AraG)-for dCK and deoxyguanosine kinase (dGK), a dCK-related mitochondrial enzyme. We demonstrate that, in the tracer concentration range used for PET imaging, [(18)F]CFA is primarily a substrate for dCK, with minimal cross-reactivity. In contrast, [(18)F]F-AraG is a better substrate for dGK than for dCK. [(18)F]CFA accumulation in leukemia cells correlated with dCK expression and was abrogated by treatment with a dCK inhibitor. Although [(18)F]CFA uptake was reduced by deoxycytidine (dC) competition, this inhibition required high dC concentrations present in murine, but not human, plasma. Expression of cytidine deaminase, a dC-catabolizing enzyme, in leukemia cells both in cell culture and in mice reduced the competition between dC and [(18)F]CFA, leading to increased dCK-dependent probe accumulation. First-in-human, to our knowledge, [(18)F]CFA PET/CT studies showed probe accumulation in tissues with high dCK expression: e.g., hematopoietic bone marrow and secondary lymphoid organs. The selectivity of [(18)F]CFA for dCK and its favorable biodistribution in humans justify further studies to validate [(18)F]CFA PET as a new cancer biomarker for treatment stratification and monitoring.en_US
dc.description.sponsorshipGrant Support: P50 CA086306/CA/NCI NIH HHS/United States R01 CA187678/CA/NCI NIH HHS/United Statesen_US
dc.language.isoen_USen_US
dc.publisherNational Academy of Sciencesen_US
dc.subjectPET imagingen_US
dc.subjectcanceren_US
dc.subjectdeoxycytidine kinaseen_US
dc.subjectnucleotide metabolismen_US
dc.title[18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity.en_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record